相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Expanding Clinical Spectrum of Extracardiovascular and Cardiovascular Manifestations of Heritable Thoracic Aortic Aneurysm and Dissection
Timothy J. Bradley et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration
Alex Pitcher et al.
AMERICAN HEART JOURNAL (2015)
Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome
Romy Franken et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Marfan Sartan: a randomized, double-blind, placebo-controlled trial
Olivier Milleron et al.
EUROPEAN HEART JOURNAL (2015)
TGF-β signalopathies as a paradigm for translational medicine
Elyssa Cannaerts et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2015)
The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele
Melodie Aubart et al.
HUMAN MOLECULAR GENETICS (2015)
SMAD2 Mutations Are Associated with Arterial Aneurysms and Dissections
Dimitra Micha et al.
HUMAN MUTATION (2015)
Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections
Aida M. Bertoli-Avella et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Exome sequencing identifies a novel heterozygous TGFB3 mutation in a disorder overlapping with Marfan and Loeys-Dietz syndrome
Alma Kuechler et al.
MOLECULAR AND CELLULAR PROBES (2015)
Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome
Ami B. Bhatt et al.
VASCULAR MEDICINE (2015)
Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome
Romy Franken et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome
Jefferson J. Doyle et al.
ELIFE (2015)
Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes
J. R. Cook et al.
CLINICAL GENETICS (2015)
The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome
Dorien Schepers et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events
Linnea M. Baudhuin et al.
GENETICS IN MEDICINE (2015)
Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation
Marco Ritelli et al.
BMC MEDICAL GENETICS (2014)
Loeys-Dietz syndrome: a primer for diagnosis and management
Gretchen MacCarrick et al.
GENETICS IN MEDICINE (2014)
Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis
Elena M. Gahllo et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome
R. V. Lacro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Absence of Cardiovascular Manifestations in a Haploinsufficient Tgfbr1 Mouse Model
Marjolijn Renard et al.
PLOS ONE (2014)
Usefulness of Losartan on the Size of the Ascending Aorta in an Unselected Cohort of Children, Adolescents, and Young Adults With Marfan Syndrome
Christiane Pees et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Genetics of Thoracic Aortic Aneurysm: At the Crossroad of Transforming Growth Factor- Signaling and Vascular Smooth Muscle Cell Contractility
Elisabeth Gillis et al.
CIRCULATION RESEARCH (2013)
Homozygosity for a FBN1 missense mutation causes a severe Marfan syndrome phenotype
J. Hogue et al.
CLINICAL GENETICS (2013)
Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome
Romy Franken et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Losartan Added to β-Blockade Therapy for Aortic Root Dilation in Marfan Syndrome: A Randomized, Open-Label Pilot Study
Hsin-Hui Chiu et al.
MAYO CLINIC PROCEEDINGS (2013)
In-Frame Mutations in Exon 1 of SKI Cause Dominant Shprintzen-Goldberg Syndrome
Virginie Carmignac et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Marfan syndrome: from gene to therapy
Nikhita Bolar et al.
CURRENT OPINION IN PEDIATRICS (2012)
Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome
Ingrid M. B. H. van de Laar et al.
JOURNAL OF MEDICAL GENETICS (2012)
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm
Mark E. Lindsay et al.
NATURE GENETICS (2012)
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome
Catherine Boileau et al.
NATURE GENETICS (2012)
Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm
Alexander J. Doyle et al.
NATURE GENETICS (2012)
Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene
Mileny E. S. Colovati et al.
MOLECULAR CYTOGENETICS (2012)
The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan's syndrome: a meta-analysis
Linggen Gao et al.
ACTA PAEDIATRICA (2011)
TGFBR2 Deletion in a 20-Month-Old Female With Developmental Delay and Microcephaly
Ian M. Campbell et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis
Umberto Benedetto et al.
HEART (2011)
Lessons on the pathogenesis of aneurysm from heritable conditions
Mark E. Lindsay et al.
NATURE (2011)
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1
David R. Goudie et al.
NATURE GENETICS (2011)
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis
Ingrid M. B. H. van de laar et al.
NATURE GENETICS (2011)
Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
Tammy M. Holm et al.
SCIENCE (2011)
The Loeys-Dietz syndrome: an update for the clinician
Christine Van Hemelrijk et al.
CURRENT OPINION IN CARDIOLOGY (2010)
Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity
Daniel Horbelt et al.
JOURNAL OF CELL SCIENCE (2010)
The revised Ghent nosology for the Marfan syndrome
Bart L. Loeys et al.
JOURNAL OF MEDICAL GENETICS (2010)
Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome
Wanfen Xiong et al.
JOURNAL OF VASCULAR SURGERY (2008)
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome
Benjamin S. Brooke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: A time for re-appraisal
Balu Vaidyanathan
ANNALS OF PEDIATRIC CARDIOLOGY (2008)
Medical treatment of Marfan syndrome: a time for change
A. Williams et al.
HEART (2008)
Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome
Gabor Matyas et al.
HUMAN GENETICS (2007)
Early surgical experience with Loeys-Dietz:: A new syndrome of aggressive thoracic aortic aneurysm disease
Jason A. Williams et al.
ANNALS OF THORACIC SURGERY (2007)
Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome
Magalie Ladouceur et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states
Ronald D. Cohn et al.
NATURE MEDICINE (2007)
The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: A meta-analysis
Deborah R. Gersony et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Aneurysm syndromes caused by mutations in the TGF-β receptor
Bart L. Loeys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited
LC Ades et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Molecular pathology of Shprintzen-Goldberg syndrome
K Kosaki et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats
P Lavoie et al.
JOURNAL OF HYPERTENSION (2005)
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
BL Loeys et al.
NATURE GENETICS (2005)
Heterozygous TGFBR2 mutations in Marfan syndrome
T Mizuguchi et al.
NATURE GENETICS (2004)
Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome
DP Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Allelic variation in normal human FBN1 expression in a family with Marfan syndrome:: a potential modifier of phenotype?
S Hutchinson et al.
HUMAN MOLECULAR GENETICS (2003)
The oncoprotein ski acts as an antagonist of transforming growth factor-β signaling by suppressing Smad2 phosphorylation
C Prunier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
ER Neptune et al.
NATURE GENETICS (2003)
Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein
Z Isogai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects
Y Ito et al.
DEVELOPMENT (2003)
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
DS Lim et al.
CIRCULATION (2001)
Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40
F Tiecke et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
